News|Articles|January 22, 2025
Identify Optimal Biologic Candidates: Low Volume, Early Stage Developability Assessment with Aura PTx
Author(s)Halo Labs
Newsletter
Stay at the forefront of biopharmaceutical innovation—subscribe to BioPharm International for expert insights on drug development, manufacturing, compliance, and more.
Related Content
